About Zhejiang Huahai Pharmaceutical Company

The company was founded in 1989 and is headquartered in Zhejiang, China. The company currently has more than 7,000 employees and has more than 40 subsidiary companies around the world (including China, the United States, Germany, etc.); its main business covers various fields such as chemicals, biopharmaceuticals, pharmaceutical packaging, trade circulation, etc., and has established long-term and stable cooperative relationships with nearly 1,000 pharmaceutical companies around the world, providing medical and health products to more than 100 countries and regions. The company is mainly engaged in R&D, production and sales of multi-dosage generic drugs, biopharmaceuticals, innovative drugs and specialty APIs. The company's products cover cardiovascular, mental disorders, neurological and anti-infective treatment fields, mainly valsartan tablets, losartan potassium tablets, irbesartan hydrochlorothiazide tablets, paroxetine hydrochloride tablets, donepezil hydrochloride tablets, levetiracetam tablets, lamotrigine controlled release tablets, anrisotan tablets, oseltamivir phosphate capsules, etc. Corporate honors: National Integrated Maternity and Education Enterprise, National Key High-tech Enterprise, National Innovative Enterprise, National Technological Innovation Demonstration Enterprise.